GOLDMAN SACHS GROUP INC Abcellera Biologics Inc (ABCL) 13F holding

GOLDMAN SACHS GROUP INC reported 3,751,212 ABCL shares valued at $13.09B as of 2026-03-31 (CMN). Cached 13F row, not a live tape.

Not investment advice. Cached 13F row, not EDGAR XML.